SCHEMBL8685371

SCHEMBL8685371

Cc1cccc(Cn2ccc3c(/C=C4\SC(=O)NC4=O)cccc32)c1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 9/20 0.62
PIM1 P11309 1/20 0.51
PIM2 Q9P1W9 1/20 0.51
TTR P02766 3/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
AKR1B1 P15121 1/20 0.48
ALDH1A1 P00352 3/20 0.46
LMNA P02545 1/20 0.46
MAPT P10636 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
PIK3CG P48736 1/20 0.45
SLC2A1 P11166 1/20 0.44
KDM4E B2RXH2 1/20 0.43
BLM P54132 1/20 0.43
PLA2G1B P04054 1/20 0.43
POLB P06746 1/20 0.43
HTT P42858 1/20 0.43
ATG4B Q9Y4P1 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8809167 1.00 PARP1 (0.62) PARP1PIM1PIM2TTRMEN1
SCHEMBL8685959 0.89 PARP1 (0.66) PARP1TTRMEN1KMT2AAKR1B1
SCHEMBL8685962 0.89 PARP1 (0.66) PARP1TTRMEN1KMT2AAKR1B1
SCHEMBL8813667 0.89 PARP1 (0.61) PARP1PIM1PIM2TTRMEN1
SCHEMBL8690587 0.89 PARP1 (0.61) PARP1PIM1PIM2TTRMEN1
SCHEMBL8809171 0.89 PARP1 (0.48) PARP1PIM1PIM2MEN1KMT2A
SCHEMBL8685971 0.88 PARP1 (0.58) PARP1PIM1PIM2TTRMEN1
SCHEMBL8809361 0.88 PARP1 (0.58) PARP1PIM1PIM2TTRMEN1
SCHEMBL8685984 0.88 PARP1 (0.81) PARP1PIM1PIM2TTRMEN1
SCHEMBL8809769 0.88 PARP1 (0.81) PARP1PIM1PIM2TTRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5811439-A ANTIDIABETIC AGENTS; SIDE EFFECT REDUCTION; ANTILEPEMIC AGENTS SENGA PHARMACEUTICAL LABORATORY INC. (JP) 1998-09-22 US disclosed
EP-0780389-A1 Thiazolidinedione derivatives, process for their preparation and pharmaceutical compositions containing them TOBISHI PHARMACEUTICAL CO., LTD. (JP) 1997-06-25 EP disclosed